Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35
🏠 Home   ➤    Stock news

Valbiotis Shares Rise by 5.92%, Confirming a +48% Rally Over 3 Months

On Tuesday, March 31st, Valbiotis shares exhibited a significant increase, rising by 5.92% to 1.038 euros during the session. This rebound follows a slightly negative week in a generally bullish Parisian market environment, with the CAC 40 up by 0.73% during the session. The Clermont-based biotech has recorded a notable quarterly performance, gaining more than 48% over the last three months.


Valbiotis Shares Rise by 5.92%, Confirming a +48% Rally Over 3 Months

Technical Indicators and Market Behavior

During the session, the Valbiotis stock price significantly exceeded its 50-day moving average, which is at 0.96 euros, a level that coincides with the support threshold identified by technical indicators. This breakthrough confirms the upward trend that has been in place since the beginning of the year, with the price also well above the 200-day moving average, positioned at 0.83 euros. The RSI stands at 57, in a neutral zone indicating neither overbuying nor overselling, theoretically leaving room for progression before reaching overheating levels. The next technical resistance is at 1.12 euros, about 8% above the current price. The monthly volatility remains high, at 24.12, characteristic of a low-capitalization stock in the biotechnology sector. The beta of 0.17, however, indicates a very limited correlation with general market movements.

Market Context and Comparative Performance

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

Valbiotis's progress occurs in a session generally favorable in Paris, with the CAC 40 up by 0.73% and the SBF 120 gaining 0.77% by midday. However, the international context remains marked by a high level of tension: the VIX, an indicator of implied volatility in the American market, was at 31.05 points in its last update on March 27, up sharply by 13.16%, reflecting an environment of extreme stress in the American options markets. Over a year, Valbiotis's performance remains slightly negative, with a decline of 3.28%. It is primarily the last three months that have seen the stock significantly correct its trajectory, with a quarterly gain of 48.29% allowing the price to move back above the symbolic 1 euro threshold. The session of the day confirms this catch-up dynamic, with the stock having closed the previous day at 0.98 euros before crossing this threshold again on Tuesday.

Related


Sector Industrie Pharmaceutique et Biotechnologie Biotechnologie


Assurance vie

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit